Kura Oncology KURA
NASDAQ KURA
$10.70 +0.06 (+0.52%)
As of: Oct 2, 2026 · 2:00 PM EDT

Kura Oncology (KURA) Other Non-Current Liabilities (2014 - 2026)

Updated

Kura Oncology (KURA) reported Other Non-Current Liabilities of $3.62 million for Q2 2026, up 39.3% from $2.6 million a year earlier and up 5.2% from the prior quarter.

Analysis

Kura Oncology (KURA) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Kura Oncology posted Other Non-Current Liabilities of $3.17 million, up 76.3% from FY2024.

  • Other Non-Current Liabilities has increased for three consecutive years, with a five-year compound annual growth rate of 51.6% (FY2020 to FY2025).
  • By year, Other Non-Current Liabilities came in at $1.8 million in FY2024 (+154.6%), $705,000 in FY2023 (+166.0%), $265,000 in FY2022 (-29.3%) and $375,000 in FY2021 (-5.1%).
  • The Q2 2026 figure ranks as the highest quarterly Other Non-Current Liabilities in data going back to Q4 2014.
  • Year over year, Other Non-Current Liabilities has now increased in each of the last 13 quarters, with growth averaging 104.8% over the last eight quarters.
  • The high point for year-over-year Other Non-Current Liabilities in five years was Q1 2024 (growth of 170.9%); the low point was Q4 2022 (a decline of 29.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.44 million (Q1 2026), $3.17 million (Q4 2025) and $2.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kura Oncology 952.70 Mn 952.70 Mn 20.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.62 Mn
Mar 31, 2026 3.44 Mn
Dec 31, 2025 3.17 Mn
Sep 30, 2025 2.98 Mn
Jun 30, 2025 2.60 Mn
Mar 31, 2025 2.14 Mn
Dec 31, 2024 1.80 Mn
Sep 30, 2024 1.47 Mn
Jun 30, 2024 1.18 Mn
Mar 31, 2024 951,000.00
Dec 31, 2023 705,000.00
Sep 30, 2023 567,000.00
Jun 30, 2023 461,000.00
Mar 31, 2023 351,000.00
Dec 31, 2022 265,000.00
Sep 30, 2022 542,000.00
Jun 30, 2022 459,000.00
Mar 31, 2022 496,000.00
Dec 31, 2021 375,000.00
Sep 30, 2021 356,000.00
API Access

Kura Oncology Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KURA&period=max&api_key=YOUR_API_KEY